Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern

查看全文 作　　者：Jingwen [1]Ai;Haocheng [1]Zhang;Qiran [1]Zhang;Yi [1]Zhang;Ke [1]Lin;Zhangfan [1]Fu;Jieyu [1]Song;Yuanhan [1]Zhao;Mingxiang [1]Fan;Hongyu [1]Wang;Chao [1]Qiu;Yang [1]Zhou;Wenhong [1,2,3]Zhang

机构地区：[1]Department of Infectious Diseases,National Medical Center for Infectious Diseases,Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response,Huashan Hospital,Shanghai Medical College,Fudan University,Shanghai,China;[2]National Clinical Research Center for Aging and Medicine,Huashan Hospital,Fudan University,Shanghai,China;[3]Key Laboratory of Medical Molecular Virology(MOE/MOH)Shanghai Medical College,Fudan University,Shanghai,China

出　　处：《Cell Research》索引2022年第32卷第1期,共4页

基　　金：supported by the National Natural Science Foundation of China(82041010);the Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response(20dz2260100);the Key Discipline Construction Plan from Shanghai Municipal Health Commission(GWV-10.1-XK01). 摘　　要：Dear Editor,As of October,2021,SARS-CoV-2 has infected more than 230 million people;promoting roll-out vaccinations could help build herd immunity for the pandemic.However,the waning of antibody in magnitude and decreased protective efficacy in multiple types of vaccines have been reported. 关键词：RBD protective NEUTRAL

相关文献

参考文献（10）
引证文献（25）
耦合文献（0）

参考文献(10)

引证文献(25)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern

参考文献(10)

引证文献(25)

用户提示